Data will be reported from across AstraZeneca’s industry-leading lung cancer portfolio at the World Conference on Lung Cancer 2015, beginning this weekend in Denver, Colorado. Presentations will feature 25 abstracts on the company’s lung cancer pipeline, designed to address the unmet needs of patients with different forms of lung cancer.
